Wallingford, PA, United States of America

Yueheng Han

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovative Contributions of Yueheng Han in Antibody Development

Introduction: Yueheng Han, an accomplished inventor based in Wallingford, Pennsylvania, has made significant strides in the field of biomedicine. His innovative work focuses on the development of anti-PSMA antibodies, which play a crucial role in targeted therapy for prostate cancer.

Latest Patents: One of Han's notable patents is titled "Anti-PSMA antibodies and use thereof." This invention pertains to compositions and methods related to antibody or antibody fragments that specifically bind to Prostate-Specific Membrane Antigen (PSMA). The patent illustrates the potential for these antibodies in advancing cancer treatment options.

Career Highlights: Currently, Yueheng Han is affiliated with Orimabs Ltd., where he utilizes his expertise to further research and development in the field of oncology. His dedication to innovation and the application of scientific knowledge has positioned him as a valuable contributor to his organization and the broader medical community.

Collaborations: Han collaborates with esteemed colleagues, including Aizhi Zhao and Weihong Wen. Together, they share a commitment to advancing research and developing effective therapeutic solutions through innovative methodologies.

Conclusion: Yueheng Han's contributions to the field of biomedicine, particularly through his patent for anti-PSMA antibodies, underscore his role as a prominent inventor. His ongoing work at Orimabs Ltd. promises to make a meaningful impact in the fight against prostate cancer, highlighting the importance of innovation in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…